相关实验视频
Updated: Feb 11, 2026

06:41
Veno-Venous Extracorporeal Membrane Oxygenation in a Mouse
Published on: October 24, 2018
13.0K
在ECMO患者中,由ECMO电路驱动的Seraph-100微绑定亲和力血液过器流量
Blood purification
|February 9, 2026
概括
将Seraph-100微结亲和血过器连接到体外膜氧化 (ECMO) 电路是可行的. 这种方法确保了足够的血液流动,可以在没有透析机的情况下去除病原体,对ECMO功能的影响最小.
科学领域:
- 关键护理医学 关键护理医学
- 生物医学工程 生物医学工程
- 传染病控制和控制传染病
背景情况:
- 赛拉夫-100微绑定亲和性血液过器是一种新型的体外疗法,用于去除血液传播的病原体.
- 赛拉夫-100的治疗疗效需要特定的血液流量,通常通过透析机实现.
- 身体外膜氧化 (ECMO) 的败血症患者可以通过ECMO电路接受Seraph-100治疗,但流量数据有限.
研究的目的:
- 评估将Seraph-100过器直接连接到ECMO电路的可行性和有效性.
- 为了确定ECMO驱动的通过Seraph-100过器的流量是否达到治疗率.
- 评估集成Seraph-100电路对ECMO系统动态的影响.
主要方法:
- 用一个猪模型来配置和测试Seraph-100电路与ECMO电路并行连接.
- 测量了Seraph-100的血流速率,使用不同的ECMO血流速率 (1.5L/分钟到5L/分钟).
- 监测了ECMO每分钟转速 (RPM) 和静脉压力的变化.
主要成果:
- 赛拉夫-100的流量从平均137.27毫升/分钟在1.5升/分钟的ECMO流量到356.50毫升/分钟在5升/分钟的ECMO流量.
- 整合Seraph-100电路使ECMO RPM增加了31.2 (p <0.05) 和静脉压降低了-3.47 mmHg (p <0.05).
- 这些调整保持了目标ECMO血流,表明可行性.
结论:
- 直接将Seraph-100过器连接到ECMO电路是可行的.
- ECMO可以有效地通过Seraph-100过器以适合临床治疗的速度驱动血液流动.
- 这种整合策略导致ECMO系统动态的最小改变,支持其在重症监护机构的使用.
更多相关视频
09:41Hemocompatibility Testing of Blood-Contacting Implants in a Flow Loop Model Mimicking Human Blood Flow
Published on: March 5, 2020
10.1K
12:43Parallel-plate Flow Chamber and Continuous Flow Circuit to Evaluate Endothelial Progenitor Cells under Laminar Flow Shear Stress
Published on: January 17, 2012
44.4K
相关概念视频
Blood Flow
76.1K
Blood is pumped by the heart into the aorta, the largest artery in the body, and then into increasingly smaller arteries, arterioles, and capillaries. The velocity of blood flow decreases with increased cross-sectional blood vessel area. As blood returns to the heart through venules and veins, its velocity increases. The movement of blood is encouraged by smooth muscle in the vessel walls, the movement of skeletal muscle surrounding the vessels, and one-way valves that prevent backflow.
76.1K
Electron Affinity
43.6K
The electron affinity (EA) is the energy change for adding an electron to a gaseous atom to form an anion (negative ion).
43.6K
Affinity and Avidity
39.2K
Overview
39.2K
Autoregulation of Blood Flow
8.2K
Autoregulation mechanisms are characterized by their inherent capacity for self-regulation without necessitating specific nervous stimulation or endocrine control. These mechanisms facilitate the adjustment of blood flow and, therefore, perfusion specific to each tissue region. This self-regulation encompasses chemical signals and myogenic controls.
Chemical Signaling in Autoregulation
Chemical signaling operates at the precapillary sphincter level, inciting either contraction or relaxation....
Chemical Signaling in Autoregulation
Chemical signaling operates at the precapillary sphincter level, inciting either contraction or relaxation....
8.2K
Passive Filters
1.0K
Passive filters are utilized to shape the frequency spectrum of signals across a diverse array of applications. These filters, using only passive elements like resistors (R), inductors (L), and capacitors (C), are capable of selectively allowing or blocking certain frequency ranges without the need for external power sources.
Low-Pass Filters
Low-pass filters are designed to transmit signals with frequencies lower than the cutoff frequency, ωc, and attenuate those above it. The cutoff...
Low-Pass Filters
Low-pass filters are designed to transmit signals with frequencies lower than the cutoff frequency, ωc, and attenuate those above it. The cutoff...
1.0K
Applications of Integration to Find Blood Flow
60
Blood flow through a cylindrical blood vessel can be mathematically described using the principles of laminar flow, a regime in which fluid moves smoothly in parallel layers. In this model, the velocity of the blood is not uniform across the cross-section of the vessel; rather, it varies with the radial distance from the center. The maximum velocity occurs along the central axis, decreasing progressively toward the vessel walls, where it reaches zero due to viscous drag.Approximating Blood...
60